Literature DB >> 7938000

11q23 translocations split the "AT-hook" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene.

N J Zeleznik-Le1, A M Harden, J D Rowley.   

Abstract

Translocations involving chromosome band 11q23, found in acute lymphoid and myeloid leukemias, disrupt the MLL gene. This gene encodes a putative transcription factor with homology to the zinc fingers and other domains of the Drosophila trithorax gene product and to the "AT-hook" motif of high mobility group proteins. To map potential transcriptional activation or repression domains of the MLL protein, yeast GAL4 DNA-binding domain and MLL hybrid protein-expressing plasmids were cotransfected with chloramphenicol acetyltransferase reporter plasmids in a transient transfection system. We found that MLL contains a strong activation domain and a repression domain. The former, located telomeric (3') to the breakpoint region, activated transcription 18-fold to > 200-fold, depending on the promoter and cell line used for transfection. A repression domain that repressed transcription 4-fold was located centromeric (5') to the breakpoint region of MLL. The MLL AT-hook domain protein was expressed in bacteria and was utilized in a gel mobility shift assay to assess DNA-binding activity. The MLL AT-hook domain could bind cruciform DNA, recognizing structure rather than sequence of the target DNA. In translocations involving MLL, loss of an activation domain with retention of a repression domain and a DNA-binding domain on the der(11) chromosome could alter the expression of downstream target genes, suggesting a potential mechanism of action for MLL in leukemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7938000      PMCID: PMC45071          DOI: 10.1073/pnas.91.22.10610

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Transcription activation by the adenovirus E1a protein.

Authors:  J W Lillie; M R Green
Journal:  Nature       Date:  1989-03-02       Impact factor: 49.962

2.  Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias.

Authors:  S Ziemin-van der Poel; N R McCabe; H J Gill; R Espinosa; Y Patel; A Harden; P Rubinelli; S D Smith; M M LeBeau; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

3.  Transcriptional repression by YY1, a human GLI-Krüppel-related protein, and relief of repression by adenovirus E1A protein.

Authors:  Y Shi; E Seto; L S Chang; T Shenk
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

4.  GAL4-VP16 is an unusually potent transcriptional activator.

Authors:  I Sadowski; J Ma; S Triezenberg; M Ptashne
Journal:  Nature       Date:  1988-10-06       Impact factor: 49.962

5.  Specific recognition of cruciform DNA by nuclear protein HMG1.

Authors:  M E Bianchi; M Beltrame; G Paonessa
Journal:  Science       Date:  1989-02-24       Impact factor: 47.728

6.  A novel repression module, an extensive activation domain, and a bipartite nuclear localization signal defined in the immediate-early transcription factor Egr-1.

Authors:  A L Gashler; S Swaminathan; V P Sukhatme
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

Review 7.  The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation.

Authors:  J Pedersen-Bjergaard; J D Rowley
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

8.  Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias.

Authors:  D C Tkachuk; S Kohler; M L Cleary
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

9.  A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias.

Authors:  M Djabali; L Selleri; P Parry; M Bower; B D Young; G A Evans
Journal:  Nat Genet       Date:  1992-10       Impact factor: 38.330

10.  Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations.

Authors:  G Cimino; D T Moir; O Canaani; K Williams; W M Crist; S Katzav; L Cannizzaro; B Lange; P C Nowell; C M Croce
Journal:  Cancer Res       Date:  1991-12-15       Impact factor: 12.701

View more
  88 in total

1.  MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein.

Authors:  P Ernst; J Wang; M Huang; R H Goodman; S J Korsmeyer
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Active repression of methylated genes by the chromosomal protein MBD1.

Authors:  H H Ng; P Jeppesen; A Bird
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

3.  The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation.

Authors:  Marco Birke; Silke Schreiner; María-Paz García-Cuéllar; Kerstin Mahr; Fritz Titgemeyer; Robert K Slany
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

4.  Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.

Authors:  Bernd B Zeisig; Tom Milne; María-Paz García-Cuéllar; Silke Schreiner; Mary-Ellen Martin; Uta Fuchs; Arndt Borkhardt; Sumit K Chanda; John Walker; Richard Soden; Jay L Hess; Robert K Slany
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

5.  Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis.

Authors:  Man Mohan; Chengqi Lin; Erin Guest; Ali Shilatifard
Journal:  Nat Rev Cancer       Date:  2010-09-16       Impact factor: 60.716

6.  Functional specificity of CpG DNA-binding CXXC domains in mixed lineage leukemia.

Authors:  Laurie E Risner; Aravinda Kuntimaddi; Alyson A Lokken; Nicholas J Achille; Noah W Birch; Kelly Schoenfelt; John H Bushweller; Nancy J Zeleznik-Le
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

7.  Chromatin control of gene expression: mixed-lineage leukemia methyltransferase SETs the stage for transcription.

Authors:  Robert K Slany
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

8.  Molecular targeting of MLL-rearranged leukemia cell lines with the synthetic peptide PFWT synergistically enhances the cytotoxic effect of established chemotherapeutic agents.

Authors:  Cecily A Bennett; Amanda C Winters; Nisha N Barretto; Charles S Hemenway
Journal:  Leuk Res       Date:  2009-02-20       Impact factor: 3.156

9.  CpG binding protein is crucial for early embryonic development.

Authors:  D L Carlone; D G Skalnik
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

Review 10.  Molecular pathogenesis of MLL-associated leukemias.

Authors:  Mariko Eguchi; Minenori Eguchi-Ishimae; Mel Greaves
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.